Figure 4From: Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation Stromal Bcl-2 staining decreases with tumor progression. Representative stromal Bcl-2 staining in normal ovary (A), serous cystadenoma (B), and moderately differentiated serous papillary carcinoma (C). (Original magnification: 40×)Back to article page